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DOI: 10.1039/c2jm31174gPolymers are often employed in tissue engineering to replace damaged extracellular matrix (ECM).
During the last few decades silk proteins have been extensively investigated concerning their use as
biopolymers for the generation of biocompatible, artificial scaffolds. Including the low or absence of
immune-response and lack of cell toxicity, silk proteins present interesting properties useful for tissue
engineering and organ repair. Since cell–matrix interactions define the behaviour of cells and posterior
graft integration, this review is focused on the influence of surface properties of silk scaffolds
(wettability, charge, elasticity and biodegradability) on the biological activity (adhesion, proliferation
and/or migration) of cells cultured thereon. Further, it is highlighted how the origin of silk proteins
(natural source, regenerated or recombinantly produced), as well as the scaffold morphology and its
treatment/post-treatment influence the scaffold surface properties in the context of biomedical
applications.1. Introduction
Scientists are permanently searching for materials to support
tissue repair processes. Such biomaterials should temporarily
restore several properties of the natural extracellular matrix
(ECM), until being absorbed and replaced by de novo ECM
proteins.
Although the use of natural ECM components (i.e. collagens,
fibronectins, elastin, etc.) has been broadly investigated, theAldo Leal-Ega~na
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14330 | J. Mater. Chem., 2012, 22, 14330–14336generation of scaffolds made of natural proteins presents a major
drawback: the risk associated with contaminating viruses,
bacteria, or prions among others. Therefore, during the last few
decades, researchers have been studying new polymers for the
generation of matrices for tissue engineering.1–3
Scaffolds used in tissue repair should have several properties,
such as support of cell attachment, the lack of toxicity, the
absence of immune-response, mechanical properties similar to
the engrafted tissues, and biodegradability. Since scaffolds made
of silk proteins accomplish most of these desirable characteristics
and since they have not been linked to viral, bacterial or prionThomas Scheibel
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View Article Onlinecontaminants, silk proteins are envisioned for applications in
wound healing and tissue repair.4
Graft integration is strictly dependent on good cell–material
interactions. Therefore, we summarize the most important
surface properties of silk scaffolds (presence of cell adhesion
motifs, wettability, charge, elasticity) and report their influence
on cell adhesion, proliferation and migration, as well as their
biodegradation and a body’s immune-response.2. Silk sources for biomedical applications
Silk proteins are produced by most arthropods. Although the
best-known examples are the silks of silkworms (i.e. Bombyx
mori) and spiders (i.e. female orb-weaving spiders, such as Ara-
neus diadematus or Nephila clavipes among others), there are
reports on silks of other arthropods, such as ants (i.e. Oecophylla
smaragdina),5 lacewings (i.e. Mallada signata),6 Caddisflies,7 or
honeybees.8
Historically, Greeks and Romans used natural spider webs for
covering wounds, and during the last few centuries degummed
Bombyx mori fibroin was extensively utilized as a suture mate-
rial.9 Nowadays, potential applications of natural silk fibres are
under extensive investigation in a wide spectrum of biomedical
applications, including chirurgical materials (i.e. sutures),10 or
the use of simple fibrous silk scaffolds in tissue engineering.11,12
Silk can be used ‘‘as-is’’, taken directly from the animals.
Further, silk proteins can be chemically ‘‘regenerated’’ (i.e. iso-
lated from denatured/dissolved natural silk fibers), allowing
preparation of scaffolds with non-fibrous morphologies such as
films,13,14 non-woven meshes,15,16 sponges17,18 and hydrogels,19,20
expanding the potential applications of silks in tissue engineering
by allowing the generation of complex matrices for 2D and 3D
cell culture.
Alternatively, recombinant silk proteins can be employed,21–24
which is advantageous, since the silk primary structure can be
simply modified to improve biocompatibility (i.e. by function-
alizing silk proteins with RGD domains),25 or to introduce new
properties, i.e. by the generation of hybrids with ECM proteins,
such as elastin,26,27 tropoelastin,28 collagen and fibroelastin-like
proteins29 among others. In Table 1 an overview over employed
natural, regenerated and recombinant silk proteins is given.3. Silk in tissue engineering approaches
Adhesion plays a major role for a cell’s metabolic activation, as
well as for diminishing potential risks associated with unwanted
biological responses (i.e. apoptosis or activation of oncogenes).30
Cell adhesion is a complex phenomenon, which includes cell–
cell (cell–cell junctions, occluding junctions, channel-forming
junctions, and signal-relaying junctions), and cell–matrix inter-
actions (cell–matrix junctions)31 all of which should be supported
by a biomaterial used in tissue engineering.
Cell–matrix anchorage is mediated by transmembrane
proteins (a and b integrins), which interact with specific amino
acidic sequences (adhesion domains) present in most ECM
proteins (i.e. fibronectin, collagen, elastin, etc.), yielding so-called
focal adhesions.32 Since b-integrin subunits link proteins of the
ECM with actin filaments from the cytoskeleton, focal adhesionsThis journal is ª The Royal Society of Chemistry 2012allow the direct intracellular sensing of distinct microenviron-
mental properties, such as the elasticity of the matrix.32–34
In the case of cell–biomaterial interactions, three issues are
important: (i) presence of specific motifs for cell–material
anchorage, where specific domains for cell attachment present on
the biomaterial surface are recognized by cellular integrins
generating focal adhesions between a cell and the material surface
(Fig. 1);35 (ii) unspecific interactions between cells and the
material, through ECM proteins adsorbed to the scaffold surface
mediated by its physicochemical properties (i.e. charge, wetta-
bility) (Fig. 2);36 (iii) morphological interactions between cells
and the surface, where cell anchorage is mediated by the bio-
material’s topography (Fig. 2).37,384. Cell attachment to silk surfaces
Weak cell attachment to silk scaffolds has been reported in the
past, such as for the osteoblast-like cell line Saos-2 which showed
50% less attachment to films made of B. mori silk fibroin than to
treated cell culture plates,39 or as for BALB/3T3 fibroblast
attachment to films and hydrogels made of the recombinant
spider silk protein eADF4(C16) in comparison to cell adhesion
observed on treated cell culture plates (approximately 60% and
90% less adhesion, respectively).37 Detachment forces of human
umbilical vein endothelial cells (HUVEC) cultured on B. mori
silk fibroin films are approximately 35% lower than on cell
culture plates.40 Moreover, cDNA microarray studies showed
that MG63 cells (osteoblastogenic lineage) up-regulated the
production of ECM proteins in relation to cell adhesion
(collagen type-I production and fibronectin), when they were
cultured in the presence of silk fibroin surfaces (B. mori).41
Similar results have been obtained by our group culturing BALB/
3T3 fibroblasts on films made of eADF4(C16).37 There, collagen
type-I is up-regulated by approximately 80% compared to type-I
collagen production of cells cultured on treated cell culture
plates, suggesting that collagen and/or fibronectins are likely
required to mediate the cell–surface anchorage in order to allow
the survival of cells cultured on silk films.
Cells cultured on silk films and hydrogels typically maintain
their spherical shape and generate micro-aggregates, since cell–
cell anchorage is stronger than cell–matrix interactions.37 These
cell-spheroids are very weakly bound to silk surfaces, and,
therefore, can be easily released upon low mechanical forces.37
The weak cell attachment to silk scaffolds is based on the lack of
specific domains for cell adhesion in most silk proteins (such as
the typical adhesion motif GEFYFDLRLKGDK found in
Collagen IV, YIGSR in laminin, and PHSRN and RGD in
fibronectin, as well as specific glycosylation patterns).42However,
natural silk fibroin from Antheraea mylitta contains the amino-
acid sequence RGD. Scaffolds made of this silk protein show
much better cell adhesion than other silk scaffolds, being similar
in adhesion and proliferation to films made of fibronectin, mostly
attributed to the presence of this RGD-sequence in the silk
primary structure.43
In order to improve silk scaffolds concerning cell attachment,
blends of silk and ECM proteins or the functionalization of silk
proteins with the tri-peptide RGD or other adhesion domains
have been employed.25,39,44–46J. Mater. Chem., 2012, 22, 14330–14336 | 14331
Table 1 Most commonly used silk types in in vitro cell culture and in vivo tissue repair
Silk type and source
Recombinant
protein Repetitive sequence
Relevant characteristics for
tissue repair Reference
Fibroin, Bombyx mori No GAGAGS Tested in vitro and in vivo. No
toxicity detected. Low/no
immune-response
1
Fibroin, Antheraea mylitta No GA sequences and Poly A
blocks
Contains RGD sequences. 43
Spidroin,Nephila clavipes and
Nephila spp.
No GA sequences and Poly A
blocks
Tested in vitro and in vivo. No
toxicity detected.
52
eADF4(C16) (from Araneus
diadematus)
Yes GGX sequences and Poly A
blocks
Tested in vitro. No toxicity
detected.
37
4RepCT (from Euprosthenops
australis)
Yes Poly A blocks Tested in vitro. No toxicity
detected. Good cell adhesion
and proliferation.
21
AmelF3 (from honeybee) Yes GA sequences and Poly A
blocks
Tested in vitro. No toxicity
detected.
8
Silk-elastin like protein
(SELP-47K)
Yes GAGAGS sequences from
silk fibroin and GVGVP from
elastin
Tested in vitro. No toxicity
detected.
27
Genetically engineered spider
silk block copolymers (from
Nephila clavipes)
Yes GAGAAAAAGGAG and
GGX blocks
Tested in vitro. No toxicity
detected.
88
Genetically engineered spider
silk block copolymers (from
Nephila clavipes) modified
with RGD domains
Yes GAGAAAAAGGAG and
GGX blocks
Contain RGD sequences. 25
Genetically engineered
silkworm silk functionalized
with fibronectin domains
(from Anaphe spp.)
Yes Block sequences [(AAG)6
ASTGRGDSPAAS]n and
[(AG)9ASTGRGDSPAAS]n
Tested in vitro. No toxicity
detected. Improved cell
adhesion in comparison to
wild type.
89
rS1/9 from Nephila clavipes Yes GGX sequences and Poly A
blocks
Tested in vitro. No toxicity
detected.
90
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View Article OnlineIt is important to note that the presence of RGD domains
(genetically or chemically coupled) incorporated in silk proteins
is a basis but is not sufficient to stimulate cell attachment or to
generate focal adhesions. Further, the spacing of such binding-
domains on a scaffold’s surface is of high importance, with an
optimal distance between individual adhesion domains being
below 70 nm.474.1. Charge
In the absence of specific cell adhesion domains, positive surface
charges play an important role in cell attachment. This issue has
been addressed by attaching positively charged poly-L-lysine to
the negatively charged cellular glycocalyx,48 improving cell
adhesion to films made of hyaluronic acid.49Fig. 1 Cell anchorage to silk matrices mediated by specific interactions.
14332 | J. Mater. Chem., 2012, 22, 14330–14336The density of the charges is highly important for cell
attachment, with a moderate density of positive charges
improving cell adhesion, supported by the slight increase of
hydrophilicity.50,51 High densities of charges render the surface
very hydrophilic, which then diminishes cell adhesion.51
Although a direct correlation between surface charge and cell
attachment has not been studied on silk matrices, it is interesting
to note that low cell adhesion has been observed in the case of B.
mori fibroin, which presents a high density of negative charges
(pI of 4.39), as well as in the case of the engineered spider silk
protein eADF4(C16) (pI of 3.48) (Table 2). Negative surface
charges interfere with cell–matrix interactions, hindering cell
spreading and posterior production of ECM proteins.
Silk scaffolds made of the engineered spider silk protein
4RepCT 21 (pI of 9.30) or native spider dragline silk from
Nephila spp.52 comprising proteins with pIs of 10.22 and 6.47 (for
spidroin 1 and 2, respectively) (Table 2) show good cell attach-
ment and proliferation, probably due to cell–matrix interactions
mediated by increased type-I collagen (pI 5.46) and fibronectin
(pI 5.60) adsorption.4.2. Wettability
Cell adhesion depends on the wettability of a material’s surface.
The degree of wetting is determined by a balance between
adhesive and cohesive forces, determined by the hydrophobicity/
hydrophilicity of the surface.50
Studies have shown that cell adhesion is high on weakly
hydrophilic surfaces (with water contact angles of approximatelyThis journal is ª The Royal Society of Chemistry 2012
Table 2 pI and number of charged amino acids (source: Expasy.org)
Protein
Number of
positively
charged amino
acids
Number of
negatively
charged amino
acids pI
Fibroin heavy chain
(Bombyx mori)
26 55 4.39
Fibroin light chain
(Bombyx mori)
15 22 5.06
Fibroin (Antheraea mylitta) 26 41 5.05
ADF4 (Araneus diadematus) 2 6 4.14
ADF3 (Araneus diadematus) 4 2 8.51
ADF2 (Araneus diadematus) 3 3 6.74
ADF1 (Araneus diadematus) 7 6 8.07
Spidroin 1 (Nephila clavipes) 20 4 10.22
Spidroin 2 (Nephila clavipes) 4 4 6.47
Recombinant spider silk
eADF4(C16)
1 16 3.48
Fig. 2 Cell anchorage to silk matrices mediated by unspecific
interactions.
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View Article Online60), due to an increased adsorption of ECM proteins.50,53,54
Otherwise, extremely hydrophilic or extremely hydrophobic
surfaces are traditionally used to avoid cell adhesion.50,53,54
Examples of surfaces with low/no cell adhesion are non-treated
polystyrol cell culture plates (water contact angle of approximately
90) or commercially available highly hydrophilic hydrogels,
where cell adhesion is less than 10% of that of traditional treated
cell culture plates (i.e. Corning ultra low attachment surfaces).
Therefore, tuning the surface wettability can modulate cell
adhesion. This probability has been shown by using thermores-
ponsive materials (i.e. PIPAAm polymers) which switch their
wettability with temperature, incrementing triggered hydropho-
bicity as the mechanism to induce cell detachment.55
In the case of silk films, traditionally reported values of water
contact angles (i.e. films made of eADF4(C16) and/or B. mori)
can be found between 50 and 70 depending on the film’s post-
treatment.37,39,56 In the case of films made of B. mori silk fibroin,
wettability can vary with the processing temperature, where films
cast at 50 C present lower contact angles (higher wettability)
than those cast at 20 C or 70 C.56 One example of tuning the
wettability of silk surfaces was the use of mica or sacrificial
colloidal crystal substrates to cast B. mori silk films on, obtaining
films with different contact angles (less than 40 or more than
100, respectively).57 Moreover, according to Sofia et al. B. mori
films cast from aqueous solutions exhibited water contact angles
of 55  2, while those cast from hexafluoroisopropanol (HFIP)
showed water contact angles of 67  2.39
The wettability of silk surfaces can be further modulated by
functionalizing the scaffold’s surface with polar/non-polar
groups,53 i.e. by plasma treatment of silk scaffolds with either O2
or CH4.
58 After plasma treatment, a significant increase of
adhesion and spreading of keratinocytes was observed with
respect to the control (without plasma treatment). Interestingly,
cell adhesion to scaffolds treated with O2-plasma was notably
better than to CH4-plasma-treated ones. However, the influence
of surface wettability on cell adhesion seems to be a cell-
depending phenomenon, since growth of human fibroblasts
cultured on untreated, CH4-plasma-treated or O2-plasma-treated
matrices was nearly indistinguishable.58Recombinant spider silk
4RepCT
5 2 9.30
Fibronectin (human) 203 253 5.46
Collagen type I alpha 1
(human)
128 141 5.604.3. Topology
A scaffold’s surface topography has a strong influence on cellular
morphology, polarity and cytoskeleton reorganization.59This journal is ª The Royal Society of Chemistry 2012Since cells typically adhere weakly to silk surfaces, their
topography could play a role in cell adhesion.37 When pig iliac
endothelial cells were cultured on films or nano-fibrous scaffolds
made of B. mori fibroin, cells adhered approximately 40% better
to fibrous matrices.60 According to our results, protrusion of
cellular phylopodia/lamellipodia in electrospun fibres could be
responsible for the improvement of cell adhesion and posterior
proliferation on silk fibre meshes compared to that on flat
surfaces (films).37 Furthermore, cells cultured on electrospun
meshes with different fibre diameters (between 150 and 680 nm)
showed increased proliferation rates (decreasing of doubling
time) with increasing fibre diameters. This finding is likely based
on the fact that the organization of the cytoskeleton and the
spacing between the electrospun fibres is strictly related.37
The surface roughness of silk scaffolds has no clear effect on
adhesion and/or posterior proliferation. When cells were
cultured on RGD functionalized silk films (B. mori) with
different roughness, cell orientation and alignment were influ-
enced, but not cell adhesion or proliferation.14,61 Similarly,
primary human dermal fibroblast cultured on films or electro-
spun meshes made of the positively charged 4RepCT proteins
showed only minor differences in terms of adhesion and prolif-
eration.21 In both cases, surface charge had a much higher impact
on interactions with cells than the scaffold topography.5. Surface properties of silk scaffolds in context with
immune-reactivity
An intriguing property of silks is the low level of immune-
response upon scaffold engraftment.4,62Although fibroins and/or
spidroins are typically acknowledged as non-immune reactive,
one publication indicates the presence of antibodies against the
terminal domains of spider silk proteins.63 Most of the in vivo
research performed with silk engraftments shows a weak
inflammatory response.64 However, mostly inflammatory
responses have been connected to sericin proteins, which reflectJ. Mater. Chem., 2012, 22, 14330–14336 | 14333
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View Article Onlinethe glue between fibroin-fibres of a silk cocoon, and therefore,
their use in silk scaffolds has to be avoided.65 The reported
immune activity after engraftment of scaffolds made of regen-
erated silk fibroin64,66 could also be related to scaffold toxicity67
based on solvent remnants in the material’s matrix from the
treatment and/or post-treatment of the silk scaffolds.64,66 The
remaining solvent induced a higher expression of TNF-a, INF-g,
IL-6, IL-4, and IL-13 after an in vivo implantation of fibroin
particles made of B. mori fibroin prepared in HFIP compared to
those prepared in an aqueous solution.64
One likely explanation for the high immune-compatibility of
silk scaffolds is the low macrophage adhesion and spreading on
silk films made of B. mori fibroin and the adsorption of certain
proteins involved in the activation of the immune-response (i.e.
C3 complement, among others).686. Toxicity
Besides the weak immune-response, a remarkable characteristic
of silks is the complete absence of or at highest only low toxicity.
Although differences in terms of scaffold integration (i.e.
vascularization, degradation grafts) have been attributed to the
contact with organic solvents during post-treatment,66 most
literature reports the absence of toxicity of silk proteins or silk
scaffolds (Table 1). In this context it should be mentioned that
the potential for cross-seeding of amyloidogenic peptides with
silk structures might exist, since amyloid peptides have been
shown to be cross-seeded from B. mori silk fibroin followed by
moderate amyloid accumulation in tissues in vivo.697. Mechanical properties of silk scaffolds used in
biomedicine
Mediated by active focal adhesions, surface elasticity is sensed by
attached cells in a process known as mechanotransduction.70
As commented previously, integrins are constituted by two
associated glycoproteins (a and b subunits), which exhibit an
intracellular and an extracellular domain. In case of activated
focal adhesions, the intracellular part of the b-subunit binds to
actin microfilaments (i.e. via the G-protein talin), allowing the
transduction of the external mechanical stimuli into intracellular
responses.32,71 Cells dynamically and constantly sense and tune
the matrix surface elasticity, regulating their activity, as well as
the properties of the surrounding ECM, such as stiffness and
pore size distribution, by modifying the synthesis of de novo
ECM proteins, regulating ECM protein degradation, and/or
initiating their crosslinking.32,70,71
Clearly, cells can recognize mechanical properties of a materi-
al’s surface, which influences their metabolic activity, prolifera-
tion, migration, or differentiation.32,34,70 Regarding the
mechanical properties of biomaterials used in tissue engineering
it is therefore necessary to generate matrices with similar
mechanical properties as found in tissues or organs. Gilbert
et al.72 showed that stem cells pre-cultured on a 2D hydrogel
surface with similar rigidity as the engrafted tissue (stiffness of
around 10 kPa, measured as Young’s modulus), presented
a much better in vivo engrafting than those cultured on treated
cell culture plates (stiffness of approximately 3 GPa), which
exhibited no posterior in vivo expansion and differentiation.14334 | J. Mater. Chem., 2012, 22, 14330–14336Mismatched mechanical properties can potentially activate
unwanted biological responses, like those associated with
a pathology or disease, i.e. in the case of a healthy liver which
exhibits a stiffness between 1 and 5 kPa, a fibrotic response (i.e.
triggered by hepatitis) can be activated, incrementing values of
stiffness up to approximately 70 kPa (fibrotic liver).73,74
In natural silk fibres, surface stiffness is in the regime of GPa.75
Since most tissues and organs from vertebrates exhibit values of
stiffness less than 200 kPa,4 the use of natural silk fibres as
scaffolds for tissue engineering is inadequate from a mechanical
point of view.
In order to tune the mechanical properties of silk scaffolds,
blends with elastic proteins of the extracellular matrix are an
appropriate tool. Films made of blends of B. mori fibroin and
tropoelastin showed an increased biocompatibility and cell
adhesion in comparison to plain B. mori silk films.28 However,
only films made of 90% tropoelastin and 10% silk fibroin showed
clearly different mechanical properties in contrast to films made
of 100% silk.28 In the case of blends of elastin and silk fibroin (B.
mori), a clear diminution of the stiffness was observed already
when using a 50/50 blend (with the Young’s modulus changing
from approximately 25 MPa to 5 MPa).76
For replacing soft tissue the best option might be silk hydro-
gels.20,77 Gels made of the recombinant spider silk eADF4(C16)
exhibited Young’s moduli between 1 kPa and 20 kPa,77
mimicking mechanical properties of very soft tissues, such as
liver tissue (1.5–5.0 kPa)78 or the nucleus pulposus in interver-
tebral discs (5.8 kPa).79
However, when human mesenchymal stem cells were entrap-
ped in silk hydrogels (i.e. made of B. mori fibroin) they exhibited
only a short phase of proliferation followed by a decay stage,20
which could be due to solid stress80 and/or pore coarsening at the
cell–hydrogel interface as a consequence of cell proliferation.73,818. Biodegradation of silk scaffolds
With the exception of permanent prosthesis, biodegradation of
artificial matrices used in tissue engineering is a requisite. Scaf-
fold degradation allows the replacement of the biomaterial
residues by de novo synthesized extracellular matrix proteins and
the morphogenesis of new tissue required for proper wound
healing.82
Biodegradation of artificial scaffolds is mediated by cell–
matrix interactions (i.e. cell-secreted and/or membrane-associ-
ated proteases).83,84 Most of the proteases in tissue repair are
endopeptidases from the family of metalloproteinases (MMPs)
which are characterized by the involvement of Zn2+ or Ca2+ ions
in their active site. MMPs are naturally responsible for degra-
dation, synthesis and activation of ECM proteins.83–85
Concerning degradation of silk scaffolds by MMPs, not much
is known. Studies on the biodegradation of silk scaffolds (i.e.
made of B. mori silk fibroin) often used ‘‘model proteases’’ such
as protease XIV (from Streptomyces griseus), Collagenase IA
(from Clostridium histolyticum), protease mycolysin/pronase
(from Mycolysin streptomyces), trypsin, and a-chymotrypsin,
which however, do not represent the proteases of the in vivo
micromilieu during wound healing.
With respect to in vivo biodegradation of silk scaffolds (made
of B. mori fibroin), experiments show the partial degradation ofThis journal is ª The Royal Society of Chemistry 2012
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View Article Onlinefibroin particles (intramuscularly implanted) in a timeframe of 6
months to one year, indicating that silk fibroins (when processed
into a solid structure) are very slowly degraded in vivo.64 The high
crystallinity of the silk protein structure in scaffolds could be one
reason for restricting the interactions between MMP active sites
and the protein backbone. Since cell attachment to silk scaffolds
is typically low, and since the activity and secretion of MMPs is
mediated by the presence of active focal adhesions,86 this repre-
sents another reason for the slow biodegradation of silk matrices.
9. Outlook: replacing the extracellular matrix by
silk materials
The extracellular matrix (ECM) is a complex network of proteins
and polysaccharides surrounding cells in tissues. The ECM
defines the extracellular micro-architecture in terms of adhesion,
maintains the tensile strength, facilitates cell migration, guides
tissue morphogenesis and repair, regulates activity of secreted
proteins, and is involved in cell–cell communication acting as
a quasi co-receptor.
In tissue engineering approaches, scaffolds made of biocom-
patible polymers should replace the function of the ECM.35,87 In
order to mimic distinct properties of the natural ECM, scaffolds
made of silk proteins (natural, regenerated and/or recombinantly
produced) have been extensively studied. Surface properties of
silk scaffolds are likely responsible for their low immune-reac-
tivity. However, the absence of specific domains for cell attach-
ment, as well as the presence of negatively charged amino acid
residues in some silk proteins could be counterproductive for the
design of novel scaffolds useful for biomedical applications.
In order to avoid complications such as contaminants, chem-
ically and genetically modified silks gain more and more impact
in biomaterials research. In the context of good mechanical
properties and slow biodegradation, the genetic modification of
silk proteins seems to be an excellent way to achieve functional
similarities to compounds of the natural ECM.
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